Psychiatric and neuropsychological characterization of Pallister-Hall syndrome

Clinical Genetics

Volumn 67, Issue 1, 2005, Pages 87-92

  Azzam, Amin ^a,b   Lerner, D M ^a   Peters, K F ^c   Wiggs, E ^a   Rosenstein, D L ^a   Biesecker, L G ^c  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

Ethics; Genetic counseling; Psychiatric disorder; Psychological testing; Single gene disorders

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FREQUENCY ANALYSIS; GROWTH RETARDATION; HUMAN; INTERVIEW; MALE; MENTAL DISEASE; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; PALLISTER HALL SYNDROME; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHIATRIC DIAGNOSIS; RARE DISEASE; SCHOOL CHILD; SELF REPORT;

ABNORMALITIES, MULTIPLE; ADOLESCENT; ADULT; AGED; CHILD; DEVELOPMENTAL DISABILITIES; GENES, DOMINANT; HAMARTOMA; HUMANS; HYPOTHALAMIC DISEASES; MENTAL DISORDERS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PHENOTYPE; POLYDACTYLY; PROSPECTIVE STUDIES; SYNDROME;

EID: 12744253874     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2005.00370.x     Document Type: Article

References (50)

1. Hall JG, Pallister PD, Clarren SK et al. Congenital hypothalamic hamartoblastoma, hypopituitarism, imperforate anus and postaxial polydactyly - a new syndrome? Part I: clinical, causal, and pathogenetic considerations. Am J Med Genet 1980: 7 (1): 47-74.
2. Biesecker LG, Graham JM Jr. Pallister-Hall syndrome. J Med Genet 1996: 33 (7): 585-589.
3. Encha-Razavi F, Larroche JC, Roume J et al. Congenital hypothalamic hamartoma syndrome: nosological discussion and minimum diagnostic criteria of a possibly familial form. Am J Med Genet 1992: 42 (1): 44-50.
4. Feuillan P, Peters KF, Cutler GB Jr, Biesecker LG. Evidence for decreased growth hormone in patients with hypothalamic hamartoma due to Pallister-Hall syndrome. J Pediatr Endocrinol Metab 2001: 14 (2): 141-149.
5. Huff DS, Fernandes M. Two cases of congenital hypothalamic hamartoblastoma, polydactyly, and other congenital anomalies (Pallister-Hall syndrome). N Engl J Med 1982: 306 (7): 430-431.
6. Kuller JA, Cox VA, Schonberg SA, Golabi M. Pallister-Hall syndrome associated with an unbalanced chromosome translocation. Am J Med Genet 1992: 43 (3): 647-650.
7. Ondrey F, Griffith A, Van Waes C et al. Asymptomatic laryngeal malformations are common in patients with Pallister-Hall syndrome. Am J Med Genet 2000: 94 (1): 64-67.
8. Pallister PD, Hecht F, Herrman J. Three additional cases of the congenital hypothalamic "hamartoblastoma" (Pallister-Hall) syndrome. Am J Med Genet 1989: 33 (4): 500-501.
9. Biesecker LG, Abbott M, Allen J et al. Report from the workshop on Pallister-Hall syndrome and related phenotypes. Am J Med Genet 1996: 65 (1): 76-81.
10. Grebe TA, Clericuzio C. Autosomal dominant inheritance of hypothalamic hamartoma associated with polysyndactyly: heterogeneity or variable expressivity? Am J Med Genet 1996: 66 (2): 129-137.
11. Iafolla K, Fratkin JD, Spiegel PK, Cohen MM Jr, Graham JM Jr. Case report and delineation of the congenital hypothalamic hamartoblastoma syndrome (Pallister-Hall syndrome). Am J Med Genet 1989: 33 (4): 489-499.
12. Kuo JS, Casey SO, Thompson L, Truwit CL. Pallister-Hall syndrome: clinical and MR features. Am J Neuroradiol 1999: 20 (10): 1839-1841.
13. Low M, Moringlane JR, Reif J et al. Polysyndactyly and asymptomatic hypothalamic hamartoma in mother and son: a variant of Pallister-Hall syndrome. Clin Genet 1995: 48 (4): 209-212.
14. Verloes A. Numerical syndromology: a mathematical approach to the nosology of complex phenotypes. Am J Med Genet 1995: 55 (4): 433-443.
15. Topf KF, Kletter GB, Kelch RP, Brunberg JA, Biesecker LG. Autosomal dominant transmission of the Pallister-Hall syndrome. J Pediatr 1993: 123 (6): 943-946.
16. Kang S, Allen J, Graham JM Jr et al. Linkage mapping and phenotypic analysis of autosomal dominant Pallister-Hall syndrome. J Med Genet 1997: 34 (6): 441-446.
17. Ruppert JM, Vogelstein B, Arheden K, Kinzler KW. GLI3 encodes a 190-kilodalton protein with multiple regions of GLI similarity. Mol Cell Biol 1990: 10 (10): 5408-5415.
18. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association Press, 1994.
19. Segal DL, Hersen M, Van Hasselt VB. Reliability of the structured clinical interview for DSM-III-R: an evaluative review. Compr Psychiatry 1994: 35 (4): 316-327.
20. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961: 4: 561-571.
21. Spielberger CD, Gorsuch RL, Lushene R, Vagg PR, Jacobs GA. Manual for the State-Trait Anxiety Inventory (Form Y). Palo Alto: Mind Garden, 1983.
22. Costa PT, McCrae RR. Revised NEO PI-R & NEO FFI Professional Manual. Odessa: Psychological Assessment Resources, Inc., 1992.
23. Wechsler D. Weschler Adult Intelligence Scale, 3rd edn. San Antonio: The Psychological Corporation, 1997.
24. Loong D. Wisconsin Card Sorting Test Computer Version. San Luis Obispo: Wang Neuropsychological Laboratories, 1988.
25. Reitan RM, Wolfson D. The Halstead-Reitan Neuropsychological Test Battery. Tucson: Neuropsychology Press, 1985.
26. Benton AL, Hamsher K, Sivan AB. Multilingual Aphasia Examination. Iowa City: AJA Associates Inc, 1983.
27. Wechsler D. Wechsler Memory Scale, 3rd edn. San Antonio: The Psychological Corporation, 1997.
28. Wechsler D. Wechsler Intelligence Scale for Children, 3rd edn. San Antonio: The Psychological Corporation, 1991.
29. Blacker D. Psychiatric Rating Scales. In: Kaplan & Sadock's Comprehensive Textbook of Psychiatry, Vol 1, 7th edn (Sadock BJ, Sadock VA, eds). Philadelphia: Lippincott Williams & Wilkins, 2000, 755-783.
30. Oei TP, Evans L, Crook GM. Utility and validity of the STAI with anxiety disorder patients. Br J Clin Psychol 1990: 29 (Pt 4): 429-432.
31. Fisher PL, Durham RC. Recovery rates in generalized anxiety disorder following psychological therapy: an analysis of clinically significant change in the STAI-T across outcome studies since 1990. Psychol Med 1999: 29 (6): 1425-1434.
32. Regier DA, Myers JK, Kramer M et al. The NIMH Epidemiologic Catchment Area Program. Historical context, major objectives, and study population characteristics. Arch Gen Psychiatry 1984: 41 (10): 934-941.
33. Tohen M, Bromet E, Murphy JM, Tsuang MT. Psychiatric epidemiology. Harv Rev Psychiatry 2000: 8 (3): 111-125.
34. Nelson EC, Grant JD, Bucholz KK et al. Social phobia in a population-based female adolescent twin sample: co-morbidity and associated suicide-related symptoms. Psychol Med 2000: 30 (4): 797-804.
35. Judd LL, Kessler RC, Paulus MP, Zeller PV, Wittchen HU, Kunovac JL. Comorbidity as a fundamental feature of generalized anxiety disorders: results from the National Comorbidity Study (NCS). Acta Psychiatr Scand Suppl 1998: 393: 6-11.
36. Kendler KS, Davis CG, Kessler RC. The familial aggregation of common psychiatric and substance use disorders in the National Comorbidity Survey: a family history study. Br J Psychiatry 1997: 170: 541-548.
37. Weissman MM, Bland RC, Canino GJ et al. The cross-national epidemiology of panic disorder. Arch Gen Psychiatry 1997: 54 (4): 305-309.
38. Kessler RC, Nelson CB, McGonagle KA, Liu J, Swartz M, Blazer DG. Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. Br J Psychiatry 1996: (30): 17-30.
39. Weissman MM, Bland RC, Canino GJ et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA 1996: 276 (4): 293-299.
40. Farrell M, Howes S, Bebbington P et al. Nicotine, alcohol and drug dependence and psychiatric comorbidity. Results of a national household survey. Br J Psychiatry 2001: 179: 432-437.
41. Merikangas KR, Mehta RL, Molnar BE et al. Comorbidity of substance use disorders with mood and anxiety disorders: results of the International Consortium in Psychiatric Epidemiology. Addict Behav 1998: 23 (6): 893-907.
42. Kessler RC, Stang PE, Wittchen HU, Ustun TB, Roy-Burne PP, Walters EE. Lifetime panic-depression comorbidity in the National Comorbidity Survey. Arch Gen Psychiatry 1998: 55 (9): 801-808.
43. Cordell HJ, Olson JM. Correcting for ascertainment bias of relative-risk estimates obtained using affected-sib-pair linkage data. Genet Epidemiol 2000: 18 (4): 307-321.
44. Slager SL, Vieland VJ. Investigating the numerical effects of ascertainment bias in linkage analysis: development of methods and preliminary results. Genet Epidemiol 1997: 14 (6): 1119-1124.
45. Pal DK, Greenberg DA. Evaluating genetic heterogeneity in complex disorders. Hum Hered 2002: 53 (4): 216-226.
46. de Andrade M, Amos CI. Ascertainment issues in variance components models. Genet Epidemiol 2000: 19 (4): 333-344.
47. Frangiskakis JM, Ewart AK, Morris CA et al. LIM-kinase 1 hemizygosity implicated in impaired visuospatial constructive cognition. Cell 1996: 86 (1): 59-69.
48. Gosch A, Pankau R. Longitudinal study of the cognitive development in children with Williams-Beuren syndrome. Am J Med Genet 1996: 61 (1): 26-29.
49. Woodin M, Wang PP, Aleman D, McDonald-McGinn D, Zackai E, Moss E. Neuropsychological profile of children and adolescents with the 22q11.2 microdeletion. Genet Med 2001: 3 (1): 34-39.
50. Dykens E, Hodapp R, Finucane B. Genetics and mental retardation syndromes: A new look at behavior and interventions. Baltimore: Paul Brooks Publishing Co, 2002.